-
Something wrong with this record ?
Ellagic acid-changed epigenome of ribosomal genes and condensed RPA194-positive regions of nucleoli in tumour cells
S. Legartová, G. Sbardella, S. Kozubek, E. Bártová
Language English Country Czech Republic
Document type Journal Article, Research Support, Non-U.S. Gov't
NLK
Free Medical Journals
from 2000
Freely Accessible Science Journals
from 2000
ProQuest Central
from 2005-01-01
Health & Medicine (ProQuest)
from 2005-01-01
ROAD: Directory of Open Access Scholarly Resources
from 2000
- MeSH
- Cell Division drug effects MeSH
- Cell Nucleolus chemistry drug effects ultrastructure MeSH
- Chromosomal Proteins, Non-Histone analysis MeSH
- Dactinomycin pharmacology MeSH
- Epigenesis, Genetic drug effects MeSH
- G2 Phase drug effects MeSH
- Guanylate Cyclase analysis antagonists & inhibitors MeSH
- HeLa Cells chemistry drug effects MeSH
- Histones analysis metabolism MeSH
- Intracellular Signaling Peptides and Proteins analysis MeSH
- Ellagic Acid pharmacology MeSH
- Humans MeSH
- Methylation MeSH
- Neoplasm Proteins analysis MeSH
- Nucleolus Organizer Region chemistry drug effects ultrastructure MeSH
- DNA Damage MeSH
- Protein Processing, Post-Translational drug effects MeSH
- Promoter Regions, Genetic MeSH
- DNA, Ribosomal drug effects genetics MeSH
- RNA Polymerase I analysis MeSH
- CARD Signaling Adaptor Proteins analysis antagonists & inhibitors MeSH
- Pol1 Transcription Initiation Complex Proteins analysis MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
We studied the effect of ellagic acid (EA) on the morphology of nucleoli and on the pattern of major proteins of the nucleolus. After EA treatment of HeLa cells, we observed condensation of nucleoli as documented by the pattern of argyrophilic nucleolar organizer regions (AgNORs). EA also induced condensation of RPA194-positive nucleolar regions, but no morphological changes were observed in nucleolar compartments positive for UBF1/2 proteins or fibrillarin. Studied morphological changes induced by EA were compared with the morphology of control, non-treated cells and with pronounced condensation of all nucleolar domains caused by actinomycin D (ACT-D) treatment. Similarly as ACT-D, but in a lesser extent, EA induced an increased number of 53BP1-positive DNA lesions. However, the main marker of DNA lesions, γH2AX, was not accumulated in body-like nuclear structures. An increased level of γH2AX was found by immunofluorescence and Western blots only after EA treatment. Intriguingly, the levels of fibrillarin, UBF1/2 and γH2AX were increased at the promoters of ribosomal genes, while 53BP1 and CARM1 levels were decreased by EA treatment at these genomic regions. In the entire genome, EA reduced H3R17 dimethylation. Taken together, ellagic acid is capable of significantly changing the nucleolar morphology and protein levels inside the nucleolus.
Epigenetic MedChem Lab Università di Salerno Dipartimento di Farmacia Fisciano Salerno Italy
Institute of Biophysics Academy of Sciences of the Czech Republic v v i Brno Czech Republic
- 000
- 00000naa a2200000 a 4500
- 001
- bmc16016965
- 003
- CZ-PrNML
- 005
- 20160701082718.0
- 007
- ta
- 008
- 160614s2015 xr ad f 000 0|eng||
- 009
- AR
- 035 __
- $a (PubMed)26333121
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Legartová, Soňa $u Institute of Biophysics, Academy of Sciences of the Czech Republic, v. v. i., Brno, Czech Republic $7 _AN046546
- 245 10
- $a Ellagic acid-changed epigenome of ribosomal genes and condensed RPA194-positive regions of nucleoli in tumour cells / $c S. Legartová, G. Sbardella, S. Kozubek, E. Bártová
- 520 9_
- $a We studied the effect of ellagic acid (EA) on the morphology of nucleoli and on the pattern of major proteins of the nucleolus. After EA treatment of HeLa cells, we observed condensation of nucleoli as documented by the pattern of argyrophilic nucleolar organizer regions (AgNORs). EA also induced condensation of RPA194-positive nucleolar regions, but no morphological changes were observed in nucleolar compartments positive for UBF1/2 proteins or fibrillarin. Studied morphological changes induced by EA were compared with the morphology of control, non-treated cells and with pronounced condensation of all nucleolar domains caused by actinomycin D (ACT-D) treatment. Similarly as ACT-D, but in a lesser extent, EA induced an increased number of 53BP1-positive DNA lesions. However, the main marker of DNA lesions, γH2AX, was not accumulated in body-like nuclear structures. An increased level of γH2AX was found by immunofluorescence and Western blots only after EA treatment. Intriguingly, the levels of fibrillarin, UBF1/2 and γH2AX were increased at the promoters of ribosomal genes, while 53BP1 and CARM1 levels were decreased by EA treatment at these genomic regions. In the entire genome, EA reduced H3R17 dimethylation. Taken together, ellagic acid is capable of significantly changing the nucleolar morphology and protein levels inside the nucleolus.
- 650 _2
- $a signální adaptorové proteiny CARD $x analýza $x antagonisté a inhibitory $7 D053468
- 650 _2
- $a buněčné dělení $x účinky léků $7 D002455
- 650 _2
- $a buněčné jadérko $x chemie $x účinky léků $x ultrastruktura $7 D002466
- 650 _2
- $a chromozomální proteiny, nehistonové $x analýza $7 D002868
- 650 _2
- $a poškození DNA $7 D004249
- 650 _2
- $a ribozomální DNA $x účinky léků $x genetika $7 D004275
- 650 _2
- $a daktinomycin $x farmakologie $7 D003609
- 650 _2
- $a kyselina ellagová $x farmakologie $7 D004610
- 650 _2
- $a epigeneze genetická $x účinky léků $7 D044127
- 650 _2
- $a G2 fáze $x účinky léků $7 D016195
- 650 _2
- $a guanylátcyklasa $x analýza $x antagonisté a inhibitory $7 D006162
- 650 _2
- $a HeLa buňky $x chemie $x účinky léků $7 D006367
- 650 _2
- $a histony $x analýza $x metabolismus $7 D006657
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a intracelulární signální peptidy a proteiny $x analýza $7 D047908
- 650 _2
- $a metylace $7 D008745
- 650 _2
- $a nádorové proteiny $x analýza $7 D009363
- 650 _2
- $a organizátor jadérka $x chemie $x účinky léků $x ultrastruktura $7 D009697
- 650 _2
- $a transkripční iniciační komplex Pol1 - proteiny $x analýza $7 D035463
- 650 _2
- $a promotorové oblasti (genetika) $7 D011401
- 650 _2
- $a posttranslační úpravy proteinů $x účinky léků $7 D011499
- 650 _2
- $a RNA-polymerasa I $x analýza $7 D012318
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Sbardella, G. $u Epigenetic MedChem Lab, Università di Salerno Dipartimento di Farmacia, Fisciano, Salerno, Italy
- 700 1_
- $a Kozubek, Stanislav, $u Institute of Biophysics, Academy of Sciences of the Czech Republic, v. v. i., Brno, Czech Republic $d 1953- $7 ola2003204933
- 700 1_
- $a Bártová, Eva $u Institute of Biophysics, Academy of Sciences of the Czech Republic, v. v. i., Brno, Czech Republic $7 xx0028314
- 773 0_
- $w MED00011004 $t Folia biologica $x 0015-5500 $g Roč. 61, č. 2 (2015), s. 49-59
- 856 41
- $u https://fb.cuni.cz/file/5772/fb2015a0007.pdf $y plný text volně přístupný
- 910 __
- $a ABA008 $b A 970 $c 89 $y 4 $z 0
- 990 __
- $a 20160614 $b ABA008
- 991 __
- $a 20160627100218 $b ABA008
- 999 __
- $a ok $b bmc $g 1152703 $s 941441
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2015 $b 61 $c 2 $d 49-59 $i 0015-5500 $m Folia biologica (Praha) $n Folia biol. (Praha) $x MED00011004
- LZP __
- $b NLK118 $a Pubmed-20160614